ChemoCentryx, Inc(NASDAQ:CCXI) 
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibito...
Website: http://www.chemocentryx.com
Founded: 1996
Full Time Employees: 133 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-04-26
P
O 19.70
H 19.76
L 19.12
C 19.19
V 1,434,328
10EMA 19.19
20EMA 19.19
60EMA 19.19
120EMA 19.19
250EMA 19.19